Post by
subaru1 on Oct 03, 2023 10:49am
Settlement with Tylray
Most of us here were thinking that this long awaiting settlement would have move the stock price and create some action, Zap 0 we are still stock at $0,08 and no buyers. Mid november with the 3 qrt result might move the stock price if not we will have to wait to 2024 with the year end results and finally the the results of the first completed clinical results, wishing that they sre good. Alleysome your target $0,20 by year end and $0,70 by july 2024 are very aggressive, future will tell us.
Comment by
subaru1 on Oct 03, 2023 11:37am
Alleysome, that is something that i don't understand, if the potential of Labs is so great why nobody is knocking at the door to buy it at this level, this is mistery for me, even a JV doesn't seem to be in the box. ????
Comment by
subaru1i on Oct 03, 2023 11:46am
The fact that a mystery exists would indicate that something else exists creating the mystery in the first place. Perhaps a question for their 'traditional global pharmaceutical partner' would be in order to help solve that mystery for you. On another note, I think I prefer CDMO vs 'white label' ;-)
Comment by
subaru1i on Oct 03, 2023 12:54pm
okgonow....don't forget that management owns well over 6% of the company. I alone own nearly .4% of the company as it stands today.